Tight glycemic control and cardiovascular effects in type 2 diabetic patients
Heart Views. 2014; 15 (4): 111-120
in English
| IMEMR
| ID: emr-159876
ABSTRACT
Diabetes Mellitus [DM] with poor glycemic control is one of the leading causes for cardiovascular mortality in diabetic patients. Tight glycemic control with glycosylated haemoglobin of <7 gms% is recommended as a routine and < 6.5 gms% is recommended for young and newly diagnosed diabetics. Treatment goal aims at achieving near normal blood glucose level, and directed at management of other co morbid conditions such as obesity, hypertension and dyslipidemia. Oral hypoglycemic agents are the preferred drugs, alone or in combination. Preference for glitazones is declining due to the increasing evidences of associated adverse events. Gliptins appear as promising agents with lesser tendency to cause hypoglycemia, but their long term safety and efficacy is yet to be established. We emphasize the role of preventive measures in prediabetics and in established DM, treatment should be individualized and customized to minimize hypoglycemic effects and to retain quality of life
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Blood Glucose
/
Glycated Hemoglobin
/
Cardiovascular Diseases
/
Dipeptidyl-Peptidase IV Inhibitors
Limits:
Humans
Language:
English
Journal:
Heart Views
Year:
2014
Similar
MEDLINE
...
LILACS
LIS